Christy Wilson, Senior Director, Pharma and Biotech Segment, Elsevier’s R&D Solutions
For pharmaceutical companies, the safety of their products is of paramount concern.
Toni Jarrett, Executive Director, Advisory Services, Optimum Healthcare IT
Everyone knows that routine maintenance is required to keep a home, car or even a person in good shape and performing well.
Joanne Beck, Ph.D., Executive Vice President, Global Pharmaceutical Development & Operations, Celgene Corporation
The highly-regulated nature of the pharmaceutical industry – coupled with historically siloed organizational models and mergers and acquisitions that introduce disparate operational and IT systems to the enterprise.
Tim Jackson, VP Technology, Advanced Clinical
Margaretta Nyilas, MD, SVP, Clinical Management & Business Operations, Otsuka Pharmaceutical Development & Commercialization
The steady pace of new disruptive technologies continues to transform our personal lives, as businesses also continue to realize increasing efficiencies and cost reductions.
Charlton Park, Chief Analytics Officer at University of Utah Hospitals and Clinics
How to increase value is a question all health care providers are facing. The transformation that is necessary will require all providers to improve clinical outcomes.
James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences
It's a logical conclusion that expanding data sources in clinical trials can lead to more therapies, but does this additional data speed up or slow down a clinical trial?
Raj Bhavsar, CTO, ConnectYourCare
It is hard to believe that just ten years ago, our world revolved around paper—especially in the world of health care. Thanks to rapid technological advances, our world has vastly changed.
James Anderson, Director, Information Services - Business Relationship Management, Astellas Americas
The dramatic increase in the availability of both internal and external data is impacting the strategic goals and future plans of pharmaceutical companies.